1 Paracetamol (Acetaminophen) in stroke 2 (PAIS 2): Protocol for a randomized, placebo-controlled, double-blind clinical trial to assess the effect of high-dose paracetamol on functional outcome in patients with acute stroke and a body temperature of 36·5°C or above International Journal of Stroke, May 28, 2013
2 Controlled-release oxycodone and naloxone in the treatment of chronic low back pain: A placebo-controlled, randomized study, Pain Research and Management, May 24, 2013
3 Effect of preemptive and preventive acetaminophen on postoperative pain score: a randomized, double-blind trial of patients undergoing lower extremity surgery Journal of Clinical Anesthesia, May 22, 2013
4 Analgesic use in relation to sex hormone and prolactin concentrations in premenopausal women Cancer Causes and Control, May 21, 2013
5 Pain Relievers Do Not Cause Asthma, Study Finds The New York Times, May 22, 2013
6 Subcutaneously administered ofatumumab in rheumatoid arthritis: a phase I/II study of safety, tolerability, pharmacokinetics, and pharmacodynamics The Journal of Rheumatology, June 3, 2013
7 Acetaminophen enhances cisplatin- and paclitaxel-mediated cytotoxicity to SKOV3 human ovarian carcinoma Anticancer Research, June 10, 2013
8 Trends in the use of aspirin and nonsteroidal anti-inflammatory drugs in the general U.S. population Pharmacoepidemiology and Drug Safety, June 7, 2013 Review Article
9 Potential risk of asthma associated with in utero exposure to xenobiotics Birth Defects Research Part C: Embryo Today: Reviews, June 3, 2013 Review Article
10 AAOS releases revised clinical practice guideline for osteoarthritis of the knee EurekAlert!, June 5, 2013
Sponsor
Register now to view all the MDLinx contents (FREE)!
Login
Sponsor
Stay current - Media Tool
♦ Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More ♦
♦ Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More ♦
Close
Sponsor